How many cancer patients received a molecular diagnostic test during 2015/16 and how many patients were eligible for such testing?
Answered by Cabinet Secretary for Health, Well-being and Sport | Answered on 15/11/2016
In 2015/16, around 1250 patients received molecular diagnostic testing to predict treatment or confirm diagnosis for colorectal, lung, malignant melanoma and gastrointestinal stromal tumours. In addition, around 560 breast and ovarian cancer patients received testing for the BRCA breast cancer fault genes.
Estimates for the number patients eligible for molecular diagnostic testing are not available.